NCT02147821

Brief Summary

This prospective randomized controlled trial will examine the efficacy of reducing the number of chest tubes used in the postoperative cardiac surgery patient. Typically used are three chest tubes - two in the mediastinum and one in the pleural space, if opened. The investigators propose that removal of the pleural tube will not impact the rates of clinically significant pleural effusions post cardiac surgery. Patients will be randomized into two groups - one receiving the standard three chest tubes (standard), and the other receiving only mediastinal drains (experimental). The primary outcome will be rates of post-operative pleural effusions as determined by defined interventions, including insertion of a chest tube, thoracentesis, or return to the operating room for primary evacuation of pleural effusion or hemothorax. Secondary outcomes include length of hospital stay, length of mechanical ventilation, postoperative respiratory status, and presence/size of pleural effusions, as well as readmission for pleural effusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 28, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2014

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

May 4, 2018

Status Verified

May 1, 2018

Enrollment Period

3.3 years

First QC Date

May 22, 2014

Last Update Submit

May 2, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pleural Effusion

    Primary outcome is rate of pleural effusions in a 6 week postoperative period of CABG.

    6 weeks

Secondary Outcomes (1)

  • Postoperative Respiratory Status

    1 week after CABG

Study Arms (2)

Standard

NO INTERVENTION

Standard treatment will be defined as current practice whereby two mediastinal chest tubes are used for drainage, as well as an additional pleural tube if the pleura is opened during surgery. As part of current standard practice, the pleural and mediastinal spaces will be suctioned during the achievement of hemostasis prior to the insertion of chest tubes.

Intervention

EXPERIMENTAL

The treatment arm of the study will involve standard placement of the mediastinal tubes with the exclusion of the pleural tube.

Procedure: No Pleural Chest Tube

Interventions

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients must be undergoing CABG at our institution with the attempted harvest of a LIMA and/or RIMA
  • pleura must be entered in order for patients to be included.

You may not qualify if:

  • cardiac surgery where the pleura is not entered
  • previous surgery where the pleura was entered
  • other pre-existing pleural diseases or fibrosis
  • Patients currently participating in other studies
  • Patients presenting with emergent need for bypass

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foothills Medical Center

Calgary, Alberta, T2N 2T9, Canada

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MMgt, HBSc

Study Record Dates

First Submitted

May 22, 2014

First Posted

May 28, 2014

Study Start

August 1, 2014

Primary Completion

November 1, 2017

Study Completion

March 1, 2018

Last Updated

May 4, 2018

Record last verified: 2018-05

Locations